The pharmaceutical industry is witnessing a significant shift in diabetes therapy with the introduction of GLP-1 patches. These groundbreaking vehicles offer a likely easy choice to injections for individuals managing diabetes mellitus type 2. By circumventing the need for frequent pokes, GLP-1 p